They believe that the benefits outweigh the risks
Mexico City- The Pan American Health Organization (PAHO) recommends continuing to use the Covid-19 vaccine produced by AstraZeneca in the United States on the grounds that the benefits of this vaccine outweigh the risks.
In a press conference, Sylvain Aldighieri, Director of Covid-19 Incident Management at the Pan American Health Organization, explained that the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee has not yet found that it has not been found in certain European countries. There is a causal relationship between vaccination and coagulation disorders found in.
In addition, he said that the World Health Organization (WHO) Global Advisory Committee on Vaccine Safety is evaluating data on two batches of specific AstraZeneca vaccines produced and distributed in Europe.
Aldigieri said: “These two batches will not be distributed in the Americas through the Kuvacs mechanism because the doses shipped to our region are produced in the Republic of Korea and India.”
“For this reason, and considering that the benefits of the vaccine outweigh the risks, the Pan American Health Organization recommends that the AstraZeneca vaccine be used to face Covid-19, while the cases in Europe have been investigated and we do not expect to produce Affect the distribution of this event through the Covax mechanism.”
He added that the blood clotting found in Europe may occur in people who have been vaccinated, but it may also occur in people who have not been vaccinated. In addition, in the United States, the surveillance systems of countries that have adopted AstraZeneca doses have the following Fact: No warning signs were reported.
Mexico also received 870,000 doses of AstraZeneca vaccine from India.